期刊文献+

加味楂曲饮对实验性大鼠非酒精性脂肪肝CYP2E1mRNA及蛋白水平影响 被引量:4

Impact of JiaWei ZhaQuYin on CYP2E1mRNA and its Protein in Nonalcoholic Fatty Liver Rat
原文传递
导出
摘要 目的研究加味楂曲饮(JWZQY)干预非酒精性脂肪肝的药效学及部分作用机制。方法选用SDF级大鼠,给予高脂饲料建立非酒精性脂肪肝模型,用低、中、高剂量JWZQY进行干预,连续灌胃8周,观察肝脏组织形态学改变,检测肝组织细胞色素氧化酶P4502E1(CYP2E1)mRNA及蛋白表达水平。结果与空白组相比,模型组呈现明显脂肪变性。高、中剂量JWZQY治疗后肝脏脂肪变程度明显减轻,中剂量组CYP2E1mRNA水平明显降低、CYP2E1蛋白表达丰度明显降低。结论 JWZQY可有效防治实验性非酒精性脂肪肝,并降低模型大鼠肝组织CYP2E1 mRNA及蛋白表达水平。 Objective To study the pharmaeodynamics and its part action mechanism of JiaWei ZhaQuYin(JWZQY) intervening non - alcoholic fatty liver. Methods The study selected SDF level rats. The nonalcoholic fatty liver rat models were induced by ahigh fat diet and intervened by JWZQY for 8 weeks. The conventional oil red O method ( modified Lillie) was used to observe the morphological changes of the liver tissue. Quantitative PCR was used to detect liver tissue CYP2E1 mRNA level. Westernlaw Blo- ting was used to detect liver tissue CYP2E1 protein levels. Results The high -fat diet led to liver ceils diffuse enlargement and round in rat the hepatic lobule, the sinusoidal smaller even not visible, the cytoplasm contains a large number of red dye fat drop- lets of varying sizes, showing steatosis. High - dose and medium dose JWZQY can significantly reduce hepatic steatosis. Com- pared with the model group, CYP2ElmRNA levels in middle dose group were significantly lower, CYP2E1 protein abundance in the middle dose group was significantly lower. Conclusion JWZQY can effectively intervene in the experimental non - alcoholic fatty liver,also can reduce CYP2E1 protein and mRNA expression, suggesting that this maybe related to oxidative stress and lipid peroxide.
出处 《时珍国医国药》 CAS CSCD 北大核心 2014年第4期789-792,共4页 Lishizhen Medicine and Materia Medica Research
基金 国家自然科学基金(No.81202624 81102720 81072902) 成都中医药大学科技发展基金
关键词 加味楂曲饮 非酒精性脂肪 肝组织细胞色素氧化酶P4502E1 Jiawei ZhaQuYin Non- alcoholic fatty Cytochrome P4502E1
  • 相关文献

参考文献18

  • 1Fan JG, Farrell GC. Epidemiology of non - alcoholic fatty liver disease in China [ J]. J Hepatol,2009,50( 1 ) :204. 被引量:1
  • 2Omagari K, Kadokawa Y, Masuda J, et al. Fatty liver in non - alcoholic non -overweight Japanese adults:incidence and clinical characteristics [ J]. J Gastroenterol Hepato1,2002,17 ( 10 ) : 1098. 被引量:1
  • 3Farrell GC,Larter CZ. Nonalcoholic fatty liver disease:from steatosis to cirrhosis [ J ]. Hepatology,2006,43 (2 Suppll ) : S99. 被引量:1
  • 4de Alwis NM, Day CP. Non - alcoholic fatty liver disease : the mist gradually clears [ J ]. J Hepatol,2008,48 Suppll : S104. 被引量:1
  • 5Angulo P. GI epidemiology: nonalcoholic fatty liver disease [ J]. Ali- ment Pharmaeol Ther,2007,25 ( 8 ) : 883. 被引量:1
  • 6Caldwell SH,Crespo DM. The spectrum expanded:cryptogenic cirrhosis and the natural history of non - alcoholic fatty liver disease [ J ]. J Hepa- tol,2004,40(4) :578. 被引量:1
  • 7周显华,张传涛,郑政隆,范昕建,张莉敏,杨鸿,李白雪,张晓婷,周威龙.加味楂曲饮治疗非酒精性脂肪肝的临床疗效及机制研究[J].中国实验方剂学杂志,2013,19(5):285-288. 被引量:27
  • 8王倩,管小琴.大鼠非酒精性脂肪肝造模方法的改进[J].世界华人消化杂志,2007,15(11):1219-1224. 被引量:68
  • 9徐叔云等主编..药理实验方法学 第3版[M].北京:人民卫生出版社,2002:1937.
  • 10钟岚,范建高,王国良,吴伟清,史祺.肥胖、高脂血症性脂肪性肝炎模型的建立[J].实验动物科学与管理,2000,17(2):16-20. 被引量:139

二级参考文献26

共引文献559

同被引文献81

引证文献4

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部